Idera Pharma (IDRA) Reports In-Line Q2 Loss
Tweet
Share
E-mailGet Alerts IDRA Hot Sheet
Join SI Premium – FREE
Idera Pharma (NASDAQ: IDRA) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11).
For earnings history and earnings-related data on Idera Pharma (IDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arxis, Inc. (ARXS) Reports Q2 EPS of $0.28; offers guidance
- Northwest Pipe (NWPX) Tops Q2 EPS by 27c
- Preformed Line Products (PLPC) Tops Q2 EPS by 191c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
